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TO THE EDITOR
Seborrheic dermatitis (SD) is a chronic
inflammatory disease that compromises
skin areas rich in sebaceous glands,
such as the face, scalp, and upper
trunk. The condition is frequently ob-
served in acquired immune deficiency
syndrome patients (30–85% compared
with 3–5% of immunocompetent
adults). Its appearance is considered to
be an early marker of the evolutionary
trend of HIV infection (Gupta et al.,
2001; Gupta and Bluhm, 2004; Ashbee,
2007; Naldi and Rebora, 2009).
The cause or causes of SD and the
pathogenic role of Malassezia spp are,
at present, not completely understood
(Gupta et al., 2000; DeAngelis et al.,
2005; Tajima et al., 2008). At this time,
we can only rely on hypotheses of the
pathogenicity mechanisms and the
pathogenic determinants (Ran et al.,
1993; Brunke and Hube, 2006; Xu
et al., 2007).
Analyses of the complete genome of
Malassezia globosa and the partial
genome of M. restricta (Xu et al.,
2007) have presented gene-encoding
enzymes of the lipase and phospholi-
pase families that could explain the
lipid dependency of the genus. The
secretion of enzymes by human patho-
genic fungi has been considered an
important factor in the invasion and
dissemination in the host (Staib et al.,
1999; Descamps et al., 2002) and, thus,
it is suggested that lipases and phos-
pholipases are involved in the mechan-
isms of pathogenicity of Malassezia
spp. However, except for an early
approximation of M. globosa lipase
gene expression on human scalp, the
expression of these genes has never
been tested during disease develop-
ment (Xu et al., 2007).
In order to assess the induction of
lipases and phospholipases in SD, we
analyzed the expression profiles of
candidate virulence genes of Malassezia
spp during host infection.
A total of 40 Malassezia isolates were
obtained from four groups of individuals
(non-Malassezia lesion (NML), SD,
NMLþHIV, and SDþHIV) (Table 1).
The selection of SD and SDþHIV
patients was based on dermatologist
evaluation of the presence of erythema
and peeling in areas such as the face and
scalp. We assessed isolates for morpho-
logical and physiological features, and
we confirmed their identification by
amplification and sequencing of 5.8S
rDNA-ITS2 regions (Supplementary Ma-
terials and Methods online). Six Malas-
sezia spp strains were used as a reference
(M. furfur CBS 1878, M. sympodialis CBS
7222, M. globosa CBS 7966, M. restricta
CBS 7877, M. slooffiae CBS 7956, and
M. pachydematis CBS 1879). All of the
Malassezia species isolated from NML,
SD, NMLþHIV, and SDþHIV indivi-
duals exhibited typical morphological,
physiological, and molecular features
(Supplementary Table S1 online), with
the exception of one: M. Furfur, which
presented atypical Tween assimilation
pattern (Gonzalez et al., 2009).
We found M. restricta to be the
predominant species in all groups
of individuals, and M. furfur was found
in all groups except the SD group.
M. furfur with an atypical Tween
assimilation pattern was present
only in SDþHIV individuals, and
M. globosa was present in SD and
SDþHIV individuals. These results
coincide with previous reports (Tajima
et al., 2008; Oh et al., 2010).
For the expression assays, four
genes, Mgl0797/M. globosa LIP1,
Mgl0798/M. globosa hypothetical secre-
tory lipase, Mgl3326/M. globosa hypo-
thetical phospholipase, and Mflip 1/M.
furfur MfLIP1 were used for a quantita-
tive analysis using real-time PCR
(Supplementary Table S2 online). All
the genes were detected in all samples.
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Figure 1. Changes in expression of lipase and phospholipase genes in non-Malassezia lesion (NML),
seborrheic dermatitis (SD), SDþHIV, and NMLþHIV individuals quantified by relative qRT-PCR.
Mgl0797: NML (P¼ 0.253), SD (Po0.001), SDþHIV (P¼ 0.001), and NMLþHIV (P¼ 0.201). Mgl0798:
NML (P¼ 0.187), SD (P¼ 0.002), SDþHIV (P¼ 0.001), and NMLþHIV (P¼0.113). Mflip1: NML
(P¼0.182), SD (Po0.001), SDþHIV (P¼ 0.002), and NMLþHIV (P¼ 0.173). Mgl3326: NML
(P¼0.116), SD (P¼0.115), SDþHIV (P¼0.119), and NMLþHIV (P¼0.121).
Abbreviations: NML, non-Malassezia lesion; SD, seborrheic dermatitis
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To determine the differential expression
between individual groups, normalized
expression was compared between
them using NML as the calibrator
sample. A significant higher expression
of Mgl0797, Mgl0798, and Mflip1 was
found in SDþHIV patients (Po0.005).
The same pattern was observed in SD
individuals with the exception of Mflip1
expression that presented a downregula-
tion (Po0.005). There were no signifi-
cant differences for the Mgl3326 gene
(Figure 1).
Our results point to the possibility
that lipases may be related to the
development of SD and could be
considered as virulence factors. How-
ever, some authors support the idea that
these enzymes provide the ability to
metabolize lipids and to integrate the
fatty acids into the fungal cell wall, and
thus are very important for growth and
survival in a host environment and could
be the result of human skin adaptation
(Gupta and Bluhm, 2004; DeAngelis
et al., 2005; Tajima et al., 2008).
In this study, we demonstrated
that M. restricta is the predominant
Malassezia species in SD and SDþHIV
individuals and we evidenced potential
virulence genes expression during infec-
tion. To our knowledge this is previously
unreported. Our data prove that lipases
Mgl0797, Mgl0798, and Mflip1 are
highly expressed in SD and SDþHIV
individuals and it suggests that they
may be involved in the Malassezia spp
pathogenesis mechanism in SD.
The Ethics Committee of the Uni-
versidad de los Andes approved the
protocol. Written informed consent was
obtained from each subject before the
sampling. The investigations were con-
ducted according to the Declaration of
Helsinki Principles.
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TO THE EDITOR
The existence of an impaired skin-
barrier function in atopic eczema (AE,
also referred to as atopic dermatitis) has
been demonstrated previously, reveal-
ing the importance of the skin barrier in
the pathophysiology of AE (Jakasa et al.,
2011). Loss-of-function mutations in the
filaggrin (FLG) gene are known to be
major risk factors for developing AE
(Palmer et al., 2006). However, recent
findings report a reduced skin-barrier
function irrespective of filaggrin geno-
type, suggesting the importance of
additional factors for an impaired skin
barrier in AE (Jakasa et al., 2011).
The skin barrier is primarily provided
by the stratum corneum (SC), consisting
of enucleated cells surrounded by lipid
regions. SC lipids (primarily ceramides
(CERs), cholesterol, and free fatty acids)
form two lamellar phases: the short-
and long-periodicity phase (LPP), with
periodicities of B6 and B13 nm, re-
spectively. These periodicities were
determined by small-angle X-ray dif-
fraction (Bouwstra et al., 1991). Barrier
properties of the skin may also depend
on the lipid organization of the SC
lipids, and an altered lipid composition
or organization may cause a reduced
skin barrier in AE. Several studies have
reported on the CER composition in AE
patients (Ishikawa et al., 2010; Junger-
sted et al., 2010). In the present study,
the CER composition and lamellar lipid
organization in the SC of AE skin have
been simultaneously examined. For AE
patients, we observe drastic changes in
lipid organization, which correlate with
changes in CER composition, as com-
pared with healthy subjects.
The study was conducted in accor-
dance with the Declaration of Helsinki
Principles and approved by the Ethical
Committee of the Leiden University
Medical Center. Subjects gave written
informed consent. Six Caucasian AE
patients (23.3±5.2 years; two males)
and six Caucasian subjects without
(history of) dermatological disorders
(24.7±7.6 years; one male) were in-
cluded. The subjects did not apply any
dermatological products to their fore-
arms for at least 1 week before the
studies. To study the lipid properties
irrespective of filaggrin mutations, we
excluded subjects with any of the four
most prevalent mutations found in
European Caucasians: 2282del4, R501X,
S3247X, and R2447X, analyzed by
genotyping (Sandilands et al., 2007).
The lamellar lipid organization was
studied using 4-mm biopsies harvested
from the ventral forearm of uninvolved
skin. The local severity of uninvolved
AE skin was evaluated by local SCOR-
ing Atopic Dermatitis (Stalder and
Taieb, 1993) and was 0 for all patients.
SC was isolated by trypsin digestion
(Tanojo et al., 1997) and analyzed by
small-angle X-ray diffraction using a
microfocus beam (European Synchro-
tron Radiation Facility, Grenoble,
France), similarly as described else-
where (Bras et al., 2003). The CER
composition was examined in SC har-
vested by tape stripping uninvolved
regions from the ventral forearm (PPS
tape, Nichiban, Tokyo, Japan) close to
the region of the biopsy. Tape strip
numbers 6–9 were extracted, pooled,
and analyzed by liquid chromato-
graphy (Alliance 2695, Waters, Milford,
MA, USA) coupled to mass spectro-
metry (TSQ-Quantum, Thermo
Finnigan, San Jose, CA) (Thakoersing
et al., 2010; van Smeden et al., 2011).
The nomenclature of used CERs is
described previously (Motta et al.,
1993). Briefly, CERs contain a fatty-
acid chain (an esterified o-hydroxy
(EO), a-hydroxy (A), or non-hydroxy
(N) fatty acid) linked via an amide to a
sphingosine chain (a sphingosine (S), dihy-
drosphingosine (dS), phytosphingosine (P),
Abbreviations: AE, atopic eczema; CER, ceramide; EO, esterified o-hydroxy; LPP, long-periodicity phase;
SC, stratum corneum
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